Search all trials

Find therapies in clinical trials near you – page 4

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Dermatitis atopic

Not recruiting

Registered drug

Study on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Anb032

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Rezpegaldesleukin

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study of Baricitinib for Children and Adolescents with Moderate-to-Severe Atopic Dermatitis

Registered drug

Austria

Participants:0–17 years
Substances:Baricitinib

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on Long-Term Safety and Effectiveness of Abrocitinib for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis

Registered drug

Hungary

Participants:0–17 years · 18–64 years · 65+ years
Substances:Abrocitinib

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Humanised Igg1 Kappa Monoclonal Antibody Against Interleukin 18

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis

Registered drug

Czechia

Participants:18–64 years · 65+ years
Substances:Desoximetasone

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study on SAR444656 for Adults with Moderate to Severe Atopic Dermatitis

Investigational

Czechia

Participants:18–64 years · 65+ years

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

Registered drugNo placebo

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on the Long-term Safety and Effectiveness of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Dermatitis atopic+1

Not recruiting

Registered drug

Study of Lebrikizumab and Topical Corticosteroids for Children and Teens with Moderate-to-Severe Atopic Dermatitis

Registered drug

Czechia

Participants:0–17 years
Substances:Glucocorticoids

Contact Research Centre

Find therapies in clinical trials near you – page 4

88 trials match your criteria

Dermatitis atopic

Study on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis

Dermatitis atopic

Study on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults

Dermatitis atopic

Study of Baricitinib for Children and Adolescents with Moderate-to-Severe Atopic Dermatitis

Dermatitis atopic

Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Dermatitis atopic

Study on Long-Term Safety and Effectiveness of Abrocitinib for Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis

Dermatitis atopic

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Dermatitis atopic

Study on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis

Dermatitis atopic

Study on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis

Dermatitis atopic

Study on SAR444656 for Adults with Moderate to Severe Atopic Dermatitis

Dermatitis atopic

Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

Dermatitis atopic

Study on the Long-term Safety and Effectiveness of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Dermatitis atopic+1

Study of Lebrikizumab and Topical Corticosteroids for Children and Teens with Moderate-to-Severe Atopic Dermatitis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.